FREE ELECTRONIC LIBRARY - Dissertations, online materials

Pages:     | 1 | 2 || 4 |

«J. Funct. Biomater. 2015, 6, 634-649; doi:10.3390/jfb6030634 OPEN ACCESS Journal of Functional Biomaterials ISSN 2079-4983 ...»

-- [ Page 3 ] --

33. Danjo, Y.; Lee, M.; Horimoto, K.; Hamano, T. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol. 1994, 72, 433–437.

34. Ohashi, Y.; Dogru, M.; Tsubota, K. Laboratory findings in tear fluid analysis. Clin. Chim. Acta Int. J. Clin. Chem. 2006, 369, 17–28.

35. Seal, D.V.; McGill, J.I.; Mackie, I.A.; Liakos, G.M.; Jacobs, P.; Goulding, N.J. Bacteriology and tear protein profiles of the dry eye. Br. J. Ophthalmol. 1986, 70, 122–125.

36. Delaire, A.; Lassagne, H.; Gachon, A.M. New members of the lipocalin family in human tear fluid.

Exp. Eye Res. 1992, 55, 645–647.

37. Ahn, J.M.; Lee, S.H.; Rim, T.H.; Park, R.J.; Yang, H.S.; Kim, T.I.; Yoon, K.C.; Seo, K.Y.

Prevalence of and risk factors associated with dry eye: The Korea national health and nutrition examination survey 2010–2011. Am. J. Ophthalmol. 2014, 158, 1205–1214.

38. Paulsen, A.J.; Cruickshanks, K.J.; Fischer, M.E.; Huang, G.H.; Klein, B.E.; Klein, R.; Dalton, D.S.

Dry eye in the beaver dam offspring study: Prevalence, risk factors, and health-related quality of life. Am. J. Ophthalmol. 2014, 157, 799–806.

J. Funct. Biomater. 2015, 6 645

39. Galor, A.; Feuer, W.; Lee, D.J.; Florez, H.; Carter, D.; Pouyeh, B.; Prunty, W.J.; Perez, V.L.

Prevalence and risk factors of dry eye syndrome in a united states veterans affairs population. Am.

J. Ophthalmol. 2011, 152, 377–384.

40. Shoja, M.R.; Besharati, M.R. Dry eye after lasik for myopia: Incidence and risk factors. Eur. J.

Ophthalmol. 2007, 17, 1–6.

41. De Paiva, C.S.; Chen, Z.; Koch, D.D.; Hamill, M.B.; Manuel, F.K.; Hassan, S.S.; Wilhelmus, K.R.;

Pflugfelder, S.C. The incidence and risk factors for developing dry eye after myopic lasik. Am. J.

Ophthalmol. 2006, 141, 438–445.

42. Lee, A.J.; Lee, J.; Saw, S.M.; Gazzard, G.; Koh, D.; Widjaja, D.; Tan, D.T. Prevalence and risk factors associated with dry eye symptoms: A population based study in indonesia. Br. J.

Ophthalmol. 2002, 86, 1347–1351.

43. Moss, S.E.; Klein, R.; Klein, B.E. Prevalence of and risk factors for dry eye syndrome. Arch.

Ophthalmol. 2000, 118, 1264–1268.

44. Alves, M.; Fonseca, E.C.; Alves, M.F.; Malki, L.T.; Arruda, G.V.; Reinach, P.S.; Rocha, E.M.

Dry eye disease treatment: A systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul. Surf. 2013, 11, 181–192.

45. Mantelli, F.; Massaro-Giordano, M.; Macchi, I.; Lambiase, A.; Bonini, S. The cellular mechanisms of dry eye: From pathogenesis to treatment. J. Cell. Physiol. 2013, 228, 2253–2256.

46. Toda, I.; Asano-Kato, N.; Hori-Komai, Y.; Tsubota, K. Ocular surface treatment before laser in situ keratomileusis in patients with severe dry eye. J. Refract. Surg. 2004, 20, 270–275.

47. Uchino, M.; Nishiwaki, Y.; Michikawa, T.; Shirakawa, K.; Kuwahara, E.; Yamada, M.; Dogru, M.; Schaumberg, D.A.; Kawakita, T.; Takebayashi, T.; et al. Prevalence and risk factors of dry eye disease in japan: Koumi study. Ophthalmology 2011, 118, 2361–2367.

48. Tsubota, K.; Nakamori, K. Dry eyes and video display terminals. N. Engl. J. Med. 1993, 328, 584.

49. Uchino, M.; Yokoi, N.; Uchino, Y.; Dogru, M.; Kawashima, M.; Komuro, A.; Sonomura, Y.; Kato, H.; Kinoshita, S.; Schaumberg, D.A.; et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: The osaka study. Am. J. Ophthalmol. 2013, 156, 759–766.

50. Kaido, M.; Ishida, R.; Dogru, M.; Tsubota, K. Visual function changes after punctal occlusion with the treatment of short but type of dry eye. Cornea 2012, 31, 1009–1013.

51. Gadaria-Rathod, N.; Lee, K.I.; Asbell, P.A. Emerging drugs for the treatment of dry eye disease.

Expert Opin. Emerging Drugs 2013, 18, 121–136.

52. Kojima, T.; Ishida, R.; Dogru, M.; Goto, E.; Matsumoto, Y.; Kaido, M.; Tsubota, K. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: A prospective randomized case-control study. Am. J. Ophthalmol. 2005, 139, 242–246.

53. Messmer, E.M. The pathophysiology, diagnosis, and treatment of dry eye disease. Deutsch.

Arztebl. Int. 2015, 112, 71–81.

54. Kojima, T.; Higuchi, A.; Goto, E.; Matsumoto, Y.; Dogru, M.; Tsubota, K. Autologous serum eye drops for the treatment of dry eye diseases. Cornea 2008, 27, S25–S30.

55. Brockes, J.P.; Kumar, A. Appendage regeneration in adult vertebrates and implications for regenerative medicine. Science 2005, 310, 1919–1923.

56. Pispa, J.; Thesleff, I. Mechanisms of ectodermal organogenesis. Dev. Biol. 2003, 262, 195–205.

J. Funct. Biomater. 2015, 6 646

57. Sakai, T. Epithelial branching morphogenesis of salivary gland: Exploration of new functional regulators. J. Med. Invest. JMI 2009, 56, 234–238.

58. Pan, Y.; Carbe, C.; Powers, A.; Zhang, E.E.; Esko, J.D.; Grobe, K.; Feng, G.S.; Zhang, X. Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 2008, 135, 301–310.

59. Makarenkova, H.P.; Ito, M.; Govindarajan, V.; Faber, S.C.; Sun, L.; McMahon, G.; Overbeek, P.A.;

Lang, R.A. FGF10 is an inducer and Pax6 a competence factor for lacrimal gland development.

Development 2000, 127, 2563–2572.

60. Dean, C.; Ito, M.; Makarenkova, H.P.; Faber, S.C.; Lang, R.A. Bmp7 regulates branching morphogenesis of the lacrimal gland by promoting mesenchymal proliferation and condensation.

Development 2004, 131, 4155–4165.

61. Tsau, C.; Ito, M.; Gromova, A.; Hoffman, M.P.; Meech, R.; Makarenkova, H.P. Barx2 and Fgf10 regulate ocular glands branching morphogenesis by controlling extracellular matrix remodeling.

Development 2011, 138, 3307–3317.

62. Govindarajan, V.; Ito, M.; Makarenkova, H.P.; Lang, R.A.; Overbeek, P.A. Endogenous and ectopic gland induction by Fgf-10. Dev. Biol. 2000, 225, 188–200.

63. Franklin, R.M. The ocular secretory immune system: A review. Curr. Eye Res. 1989, 8, 599–606.

64. Wang, Y.L.; Tan, Y.; Satoh, Y.; Ono, K. Morphological changes of myoepithelial cells of mouse lacrimal glands during postnatal development. Histol. Histopathol. 1995, 10, 821–827.

65. Payne, A.P. The harderian gland: A tercentennial review. J. Anat. 1994, 185, 1–49.

66. Satoh, Y.; Gesase, A.P.; Habara, Y.; Ono, K.; Kanno, T. Lipid secretory mechanisms in the mammalian harderian gland. Microsc. Res. Tech. 1996, 34, 104–110.

67. Sant’ Anna, A.E.; Hazarbassanov, R.M.; de Freitas, D.; Gomes, J.A. Minor salivary glands and labial mucous membrane graft in the treatment of severe symblepharon and dry eye in patients with stevens-johnson syndrome. Br. J. Ophthalmol. 2012, 96, 234–239.

68. Soares, E.J.; Franca, V.P. Transplantation of labial salivary glands for severe dry eye treatment.

Arq. Bras. Oftalmol. 2005, 68, 481–489.

69. Zoukhri, D. Mechanisms involved in injury and repair of the murine lacrimal gland: Role of programmed cell death and mesenchymal stem cells. Ocul. Surf. 2010, 8, 60–69.

70. Walker, N.I. Ultrastructure of the rat pancreas after experimental duct ligation. I. The role of apoptosis and intraepithelial macrophages in acinar cell deletion. Am J. Pathol. 1987, 126, 439–451.

71. Scoggins, C.R.; Meszoely, I.M.; Wada, M.; Means, A.L.; Yang, L.; Leach, S.D. P53-dependent acinar cell apoptosis triggers epithelial proliferation in duct-ligated murine pancreas. Am. J.

Physiol. Gastrointest. Liver Physiol. 2000, 279, G827–G836.

72. Walker, N.I.; Bennett, R.E.; Kerr, J.F. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat. 1989, 185, 19–32.

73. Sumita, Y.; Liu, Y.; Khalili, S.; Maria, O.M.; Xia, D.; Key, S.; Cotrim, A.P.; Mezey, E.; Tran, S.D.

Bone marrow-derived cells rescue salivary gland function in mice with head and neck irradiation.

Int. J. Biochem. Cell Boil. 2011, 43, 80–87.

74. Lombaert, I.M.; Brunsting, J.F.; Wierenga, P.K.; Faber, H.; Stokman, M.A.; Kok, T.; Visser, W.H.;

Kampinga, H.H.; de Haan, G.; Coppes, R.P. Rescue of salivary gland function after stem cell transplantation in irradiated glands. PloS One 2008, 3, doi:10.1371/journal.pone.0002063.

J. Funct. Biomater. 2015, 6 647

75. Feng, J.; van der Zwaag, M.; Stokman, M.A.; van Os, R.; Coppes, R.P. Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 2009, 92, 466–471.

76. Takahashi, S.; Schoch, E.; Walker, N.I. Origin of acinar cell regeneration after atrophy of the rat parotid induced by duct obstruction. Int. J. Exp. Pathol. 1998, 79, 293–301.

77. Cummins, M.; Dardick, I.; Brown, D.; Burford-Mason, A. Obstructive sialadenitis: A rat model.

J. Otolaryngol. 1994, 23, 50–56.

78. Burgess, K.L.; Dardick, I.; Cummins, M.M.; Burford-Mason, A.P.; Bassett, R.; Brown, D.H.

Myoepithelial cells actively proliferate during atrophy of rat parotid gland. Oral Surg. Oral Med.

Oral Pathol. Oral Radiol. Endod. 1996, 82, 674–680.

79. Takahashi, S.; Shinzato, K.; Domon, T.; Yamamoto, T.; Wakita, M. Mitotic proliferation of myoepithelial cells during regeneration of atrophied rat submandibular glands after duct ligation.

J. Oral Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral Pathol. 2004, 33, 430–434.

80. Takahashi, S.; Shinzato, K.; Nakamura, S.; Domon, T.; Yamamoto, T.; Wakita, M. The roles of apoptosis and mitosis in atrophy of the rat sublingual gland. Tissue Cell 2002, 34, 297–304.

81. Takahashi, S.; Nakamura, S.; Suzuki, R.; Islam, N.; Domon, T.; Yamamoto, T.; Wakita, M.

Apoptosis and mitosis of parenchymal cells in the duct-ligated rat submandibular gland. Tissue Cell 2000, 32, 457–463.

82. Kobayashi, S.; Kawakita, T.; Kawashima, M.; Okada, N.; Mishima, K.; Saito, I.; Ito, M.;

Shimmura, S.; Tsubota, K. Characterization of cultivated murine lacrimal gland epithelial cells.

Mol. Vision 2012, 18, 1271–1277.

83. You, S.; Avidan, O.; Tariq, A.; Ahluwalia, I.; Stark, P.C.; Kublin, C.L.; Zoukhri, D. Role of epithelial-mesenchymal transition in repair of the lacrimal gland after experimentally induced injury. Inv. Ophthalmol. Vis. Sci. 2012, 53, 126–135.

84. Zoukhri, D.; Fix, A.; Alroy, J.; Kublin, C.L. Mechanisms of murine lacrimal gland repair after experimentally induced inflammation. Invest. Ophthalmol. Vis. Sci. 2008, 49, 4399–4406.

85. Zoukhri, D.; Macari, E.; Kublin, C.L. A single injection of interleukin-1 induces reversible aqueous-tear deficiency, lacrimal gland inflammation, and acinar and ductal cell proliferation. Exp.

Eye Res. 2007, 84, 894–904.

86. You, S.; Kublin, C.L.; Avidan, O.; Miyasaki, D.; Zoukhri, D. Isolation and propagation of mesenchymal stem cells from the lacrimal gland. Invest. Ophthalmol. Vis. Sci. 2011, 52, 2087–2094.

87. Tiwari, S.; Ali, M.J.; Vemuganti, G.K. Human lacrimal gland regeneration: Perspectives and review of literature. Saudi J. Ophthalmol. Off. J. Saudi Ophthalmol. Soc. 2014, 28, 12–18.

88. Tiwari, S.; Ali, M.J.; Balla, M.M.; Naik, M.N.; Honavar, S.G.; Reddy, V.A.; Vemuganti, G.K.

Establishing human lacrimal gland cultures with secretory function. PloS One 2012, 7, doi:10.1371/journal.pone.0029458.

89. Purnell, B. New release: The complete guide to organ repair. Science 2008, 322, doi:10.1126/ science.322.5907.1489.

90. Kagami, H.; Wang, S.; Hai, B. Restoring the function of salivary glands. Oral Dis. 2008, 14, 15–24.

J. Funct. Biomater. 2015, 6 648

91. Oshima, M.; Mizuno, M.; Imamura, A.; Ogawa, M.; Yasukawa, M.; Yamazaki, H.; Morita, R.;

Ikeda, E.; Nakao, K.; Takano-Yamamoto, T.; et al. Functional tooth regeneration using a bioengineered tooth unit as a mature organ replacement regenerative therapy. PloS One 2011, 6, doi:10.1371/journal.pone.0021531.

92. Ikeda, E.; Morita, R.; Nakao, K.; Ishida, K.; Nakamura, T.; Takano-Yamamoto, T.; Ogawa, M.;

Mizuno, M.; Kasugai, S.; Tsuji, T. Fully functional bioengineered tooth replacement as an organ replacement therapy. Proc. Natl. Acad. Sci. USA 2009, 106, 13475–13480.

93. Sato, A.; Toyoshima, K.E.; Toki, H.; Ishibashi, N.; Asakawa, K.; Iwadate, A.; Kanayama, T.;

Tobe, H.; Takeda, A.; Tsuji, T. Single follicular unit transplantation reconstructs arrector pili muscle and nerve connections and restores functional hair follicle piloerection. J. Dermatol. 2012, 39, 682–687.

94. Asakawa, K.; Toyoshima, K.E.; Ishibashi, N.; Tobe, H.; Iwadate, A.; Kanayama, T.; Hasegawa, T.;

Nakao, K.; Toki, H.; Noguchi, S.; et al. Hair organ regeneration via the bioengineered hair follicular unit transplantation. Sci. Rep. 2012, 2, 424.

95. Toyoshima, K.E.; Asakawa, K.; Ishibashi, N.; Toki, H.; Ogawa, M.; Hasegawa, T.; Irie, T.;

Tachikawa, T.; Sato, A.; Takeda, A.; et al. Fully functional hair follicle regeneration through the rearrangement of stem cells and their niches. Nat. Commun. 2012, 3, doi:10.1038/ncomms1784.

96. Oshima, M.; Tsuji, T. Functional tooth regenerative therapy: Tooth tissue regeneration and whole-tooth replacement. Odontol. Soc. Nippon. Dent. Univ. 2014, 102, 123–136.

97. Ogawa, M.; Tsuji, T. Fully functional salivary gland regeneration as a next-generation regenerative therapy. Jpn J. Clin. Immunol. 2015, 38, 93–100.

98. Ogawa, M.; Oshima, M.; Imamura, A.; Sekine, Y.; Ishida, K.; Yamashita, K.; Nakajima, K.;

Hirayama, M.; Tachikawa, T.; Tsuji, T. Functional salivary gland regeneration by transplantation of a bioengineered organ germ. Nat. Commun. 2013, 4, doi:10.1038/ncomms3498.

99. Rock, J.R.; Hogan, B.L. Developmental biology. Branching takes nerve. Science 2010, 329, 1610–1611.

100. Kumar, A.; Brockes, J.P. Nerve dependence in tissue, organ, and appendage regeneration. Trends Neurosci. 2012, 35, 691–699.

101. Rios, J.D.; Horikawa, Y.; Chen, L.L.; Kublin, C.L.; Hodges, R.R.; Dartt, D.A.; Zoukhri, D.

Pages:     | 1 | 2 || 4 |

Similar works:

«Notice of Privacy Policies for Crossroads Eye Care Associates, Ltd 4160 Washington Rd. McMurray PA 15317 THIS INFORMATION DESCRIBES HOW INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED, AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY, PRINT IT, SIGN IT, AND RETURN IT TO US PRIOR TO YOUR APPOINTMENT. YOU MAY ALSO GIVE IT TO US AT YOUR APPOINTMENT TIME. Introduction: At Crossroads Eye Care Associates, Ltd. We are committed to treating and using protected health...»

«Statement of the American Hospital Association before the Subcommittee on Health of the Committee on Ways and Means of the U.S. House of Representatives May 11, 2016 On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our 43,000 individual members, the American Hospital Association (AHA) appreciates the opportunity to submit comments on the implementation of the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015. The implementation...»

«PROCESS EVALUATION OF THE MULTIPLE CONCURRENT PARTNERSHIPS   “O ICHEKE, BREAK THE CHAIN” CAMPAIGN FOR HIV PREVENTION IN BOTSWANA   FROM 2009 2012     EMMANUEL MAFOKO STUDENT NUMBER: 2930812 A minithesis submitted in partial fulfillment of the requirements for the degree of Master of Public Health at the School of Public Health, University of the Western Cape Supervisor: Prof. Sylvia Tilford Co-Supervisor: Ms Lucy Alexander 21st May 2013   PROCESS EVALUATION OF THE MULTIPLE CONCURRENT...»

«Assessing startle responses and their habituation in adult zebrafish Simon Chanin*, Caroline Fryar*, Danielle Varga*, Jolia Raymond, Evan Kyzar, Joseph Enriquez, Sidarth Bagawandoss, Siddharth Gaikwad, Andrew Roth, Mimi Pham, Ivan Zapolsky, Indya Bruce, Jonathan Hester, Jeremy Green, Daniel Desmond, Adam Stewart, Allan V. Kalueff** Department of Pharmacology and Neuroscience Program, Zebrafish Neuroscience Research Consortium (ZNRC), Tulane University Medical School, 1430 Tulane Ave., New...»

«' ~.d'''''~l.llVI('I'.s',O Public Health SeNice 5 (,,'f DEPARTMENT OF HEAL m & HUM SERVICES Food and Drug Administration Silver Spring, MD 20993 TRANSMITTED BY FACSIMILE Howard Solomon Chief Executive Officer Forest Laboratories, Inc. 909 Third Avenue New York, NY10022 RE: NDA #21-742 SystoliclI (nebivolol) Tablets MACMIS #16299 WARNING LETTER Dear Mr. Solomon: The Division of Drug Marketing, Advertising, and Communications (DDMAC) of the U.S. Food and Drug Administration (FDA) has reviewed an...»

«314 SYMPOSIUM 40: 450-458; GOLDBERG, L. J. AND LEIF, W. R. 1950. The use of radioactive isotopes in determining the retention and initial distribution of airbone bacteria in the mouse. Science, 112: 299-300; SONKIN, L. S. 1951. The role of particle size in experimental airborne infection. Am. J. Pub. Health. 53: 337-354. GOWEN, J. W. AND CALHOUN, M. L. 1943. Factors affecting genetic resistance of mice 2. to mouse typhoid. J. Infect. Dis. 73: 40-56. IRWIN, M. R. 1929. The inheritance of...»

«The Diagnosis of Brain Tumours in Children An evidence-based guideline to assist healthcare professionals in the assessment of children presenting with symptoms and signs that may be due to a brain tumour Quick Reference Guide endorsed by the RCPCH Version 3: March 2011 Contents of Quick Reference Guide 1. Guideline background, aim and scope p.1 2. Guideline summary p.3 3. Best practice p.4 Best practice – consultation p.4 Best practice – referral p.4 Best practice – imaging p.4 Best...»

«Detection and Prevention of Melanoma Guest Expert: David Leffell, MD Professor of Dermatology and Surgery CEO, Yale Medical Group www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Dr. Ed Chu and Dr. Ken Miller. I am Bruce Barber. Dr. Chu is Deputy Director and Chief of Medical Oncology at Yale Cancer Center and Dr. Miller is a medical oncologist specializing in pain and palliative care and he also serves as Director of the Connecticut Challenge Survivorship...»

«Tibetan Refugee Eye & Medical Project Pokhara, Nepal April 2010 The Explorers Club Flag #176 Report     Scott Hamilton, MED ’82, Expedition Leader Project Volunteers The Explorers Club Scott Hamilton, MED 82 Indira Kairam M.D.** Melissa Ryan Hamilton Steve Pearse Henry Goldstein M.D. Constance DiFede Lars Perkins Faanya Rose ** Project Medical Director Pema Ts’al Sakya Monastic Institute Lama Khunga Dhondup Khenpo Kunga Jamphal Lama Tashi Lobsang Tsering Leckshey Tenpa Leckshey Phuntsok...»

«Volume 30 (2) 2010 Editor: Contents Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Trospium Barbara Cadario Chairman, Medical Review Laird Birmingham, M.D., M.H.Sc., F.R.C.P.(C) TROSPIUM TRADE NAMES: Sanctura XR, Trosec CLASSIFICATION: Anticholinergic; muscarinic receptor antagonist ; antispasmodic; quaternary ammonium ACTION • Muscarinic receptor antagonist. Blocks the effects of acetylcholine on muscarinic receptors. • Equally selective for M1, M2, M3, M4 and M5 muscarinic receptors....»

«Slip, Trip, and Fall Prevention for Healthcare Workers DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Slip, Trip, and Fall Prevention for Healthcare Workers DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Authors Jennifer Bell, Ph.D. Research Epidemiologist Division of Safety Research National Institute for...»

«Brain Stents Artery Allies Department of Neurosurgery Introduction Brain stents are devices implanted in the brains of people with high risk conditions of the brain arteries. Brain stents save and improve lives every day, and University of Michigan specialists have developed great expertise in their use. Our team includes neurosurgeons and Neuro Interventional Radiologists (doctors with expertise in x ray guided brain procedures) as well as nurses and other health professionals. We prepared...»

<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.